Voronoi, Inc. (KOSDAQ: A310210)
Health Care · Biotechnology · KR
₩138,400.00
-3.96% today · -13.8% 1Y
Voronoi, Inc. (KOSDAQ: A310210) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.87B.
Over the last twelve months the share price has lost 13.8%, trading between 97.50K and 375.50K.
Tweenvest scores Voronoi, Inc. across four factors: quality 48/100, value 31/100. Its strongest factor is quality.
A310210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.87B
- Revenue (TTM)
- $2.69M
- P/E
- —
- EPS
- -3,806.03
- Dividend yield
- —
- Beta (5Y)
- 1.56
- 52-week high
- ₩375,500.00
- 52-week low
- ₩97,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.13M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.92B | NT$46.85 | +5.28% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $1.92B | €26.32 | +1.70% |
| Agios Pharmaceuticals, Inc.NasdaqGS: AGIO | $1.90B | $31.10 | -2.23% |
| Sarepta Therapeutics, Inc.NasdaqGS: SRPT | $1.89B | $17.56 | -1.62% |
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | $1.83B | $12.69 | -2.91% |
| Xencor, Inc.NasdaqGM: XNCR | $1.83B | $24.81 | +0.73% |
| Zymeworks Inc.NasdaqGS: ZYME | $1.83B | $25.41 | -1.47% |
| Biohaven Ltd.NYSE: BHVN | $1.82B | $11.78 | -2.48% |
Figures last refreshed Oct 11, 2026.